Literature DB >> 17536037

Lymphangioleiomyomatosis--presence of receptor tyrosine kinases and the angiogenesis factor VEGF-A as potential therapeutic targets.

Henrik Watz, Knut Engels, Siegfried Loeschke, Michael Amthor, Detlef Kirsten, Helgo Magnussen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17536037      PMCID： PMC2117228          DOI： 10.1136/thx.2006.071811

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  Modulation of cell migration and invasiveness by tumor suppressor TSC2 in lymphangioleiomyomatosis.

Authors:  Elena A Goncharova; Dmitriy A Goncharov; Poay N Lim; Daniel Noonan; Vera P Krymskaya
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-30       Impact factor: 6.914

2.  Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score.

Authors:  K Matsui; M B Beasley; W K Nelson; P M Barnes; J Bechtle; R Falk; V J Ferrans; J Moss; W D Travis
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

3.  Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor.

Authors:  Elena Lesma; Vera Grande; Stephana Carelli; Diego Brancaccio; Maria Paola Canevini; Rosa Maria Alfano; Guido Coggi; Anna Maria Di Giulio; Alfredo Gorio
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

4.  Abnormal growth of smooth muscle-like cells in lymphangioleiomyomatosis: Role for tumor suppressor TSC2.

Authors:  Elena A Goncharova; Dmitriy A Goncharov; Matthew Spaits; Daniel J Noonan; Ekaterina Talovskaya; Andrew Eszterhas; Vera P Krymskaya
Journal:  Am J Respir Cell Mol Biol       Date:  2006-01-19       Impact factor: 6.914

5.  Molecular and genetic analysis of disseminated neoplastic cells in lymphangioleiomyomatosis.

Authors:  Denise M Crooks; Gustavo Pacheco-Rodriguez; Rosamma M DeCastro; J Philip McCoy; Ji-an Wang; Fumiyuki Kumaki; Thomas Darling; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-06       Impact factor: 11.205

Review 6.  Lymphangioleiomyomatosis.

Authors:  S R Johnson
Journal:  Eur Respir J       Date:  2006-05       Impact factor: 16.671
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.